Last reviewed · How we verify
Conventional Strategy
Conventional Strategy is a treatment approach that involves a combination of medications and lifestyle changes to manage various health conditions.
Conventional Strategy is a treatment approach that involves a combination of medications and lifestyle changes to manage various health conditions. Used for Hypertension, Hyperlipidemia.
At a glance
| Generic name | Conventional Strategy |
|---|---|
| Also known as | Ticagrelor 90 mg, DAPT |
| Sponsor | Fundación para la Investigación del Hospital Clínico de Valencia |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This approach typically involves the use of multiple medications to target different aspects of a condition, such as blood pressure, cholesterol levels, and blood sugar control. The specific medications used may vary depending on the individual's needs and health status.
Approved indications
- Hypertension
- Hyperlipidemia
Common side effects
- Headache
- Dizziness
Key clinical trials
- Clinical Study of Lung Protective Ventilation Strategies and Tumor Microenvironment (NA)
- Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion (NA)
- The "CAD-Man" EXTEND Study (NA)
- Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery. (NA)
- Time Pressure Motor Training With Step Square Exercise on Stroke Patients (NA)
- The Effect of Early-Phase Graded Motor Imagery Following Massive Rotator Cuff Repair. (NA)
- The Impact of Automatic Lung Recruitment Postoperative Pulmonary Complications (NA)
- Contribution of Lower Limb Venous Colour Doppler Ultrasound in the Diagnosis of Pulmonary Embolism Recurrence
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: